Brief: Biocryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
04/12/2024 21:30
Dec 4 (Reuters) - BioCryst Pharmaceuticals Inc BCRX.O :
* BIOCRYST REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING
RULE
5635(C)(4)
Source text: ID:nGNX62JSw2
Further company coverage: BCRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on BioCryst Pharmaceuticals
See all newsUS RESEARCH ROUNDUP-Alnylam Pharmaceuticals, Carvana, MongoDB
Pharvaris' genetic disorder drug meets main goal in late-stage trial (updated)
Brief: Biocryst Announces Approval Of Orladeyo® For Pediatric Hae Patients In Japan
BioCryst Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Biocryst Pharmaceuticals, - Cash, Cash Equivalents, Restricted Cash And Investments $354 Million At June 30, 2026